M. Witzenrath (Berlin, Germany), K. Belchamber (Birmingham, United Kingdom)
Effects of PC945, a novel antifungal agent optimised for lung delivery, on Candida albicans lung infection in mice Y. Nishimoto (Funabashi, Japan), G. Kimura (Funabashi, Japan), T. Nakaoki (Funabashi, Japan), P. Strong (London, United Kingdom), K. Ito (London, United Kingdom), Y. Kizawa (Funabashi, Japan)
| |
Establishment of Nontypeable Haemophilus influenzae airway infection murine model G. Kimura (Funabashi, Japan), Y. Nishimoto (Funabashi, Japan), T. Nakaoki (Funabashi, Japan), K. Ito (London, United Kingdom), Y. Kizawa (Funabashi, Japan)
| |
Dual RNASeq unveils NTHi-macrophage transcriptomic changes during intracellular persistence J. Ackland (Southampton (Hampshire), United Kingdom), A. Heinson (Southampton (Hampshire), United Kingdom), D. Cleary (Southampton (Hampshire), United Kingdom), M. Christodoulides (Southampton (Hampshire), United Kingdom), T. Wilkinson (Southampton (Hampshire), United Kingdom), K. Staples (Southampton (Hampshire), United Kingdom)
| |
Overexpression of macrophage inducible C-type lectin Mincle aggravates proinflammatory responses to Streptococcus pneumoniae with fatal outcome in mice F. Hollwedel (Hannover, Germany), R. Maus (Hannover, Germany), J. Stolper (Hannover, Germany), A. Khan (Wellington, New Zealand), B. Stocker (Wellington, New Zealand), A. Pich (Hannover, Germany), T. Welte (Hannover, Germany), S. Yamasaki (Osaka, Japan), U. Maus (Hannover, Germany)
| |
TOLL-like receptors polymorphism in pneumonia associated with influenza A(H1N1)/09 A. Sartakova (Chita, Russian Federation), . Lukyanov (Chita, Russian Federation), . Malyarchikov (Chita, Russian Federation), J. Shchukina (Chita, Russian Federation), A. Levanchuk (Chita, Russian Federation), A. Emelyanov (Chita, Russian Federation), K. Shapovalov (Chita, Russian Federation)
| |
Biomorphological and related technical aspects affecting phage activity for inhaled application S. Wienhold (Berlin, Germany), M. Brack (Berlin, Germany), W. Groenewald (Berlin, Germany), G. Nouailles (Berlin, Germany), I. Korf (Braunschweig, Germany), M. Rohde (Braunschweig, Germany), C. Seitz (Braunschweig, Germany), A. Dannheim (Braunschweig, Germany), S. Wienecke (Braunschweig, Germany), H. Ziehr (Braunschweig, Germany), C. Rohde (Braunschweig, Germany), M. Witzenrath (Berlin, Germany)
| |
Role of reactive persulfide species in influenza virus-induced lung inflammation in mice K. Takita (Sendai, Japan), H. Sugiura (Sendai, Japan), T. Ichikawa (Sendai, Japan), N. Tadahhisa (Sendai, Japan), H. Taizou (Sendai, Japan), M. Yamada (Sendai, Japan), T. Akaike (Sendai, Japan), I. Masakazu (Sendai, Japan)
| |
Condition of cellular immunity in patients with prolonged course of community acquired pneumonia R. Razumnyi (Dnipro, Ukraine), K. Gashynova (Dnipro, Ukraine)
| |
Systematic evaluation of clarithromycin (CLA) resistance associated mutations in Mycobacterium abscessus complex based on whole-genome sequencing analysis and drug susceptibility testing. M. Yoshida (Tokyo, Japan), H. Fukano (Tokyo, Japan), K. Yamamoto (Tokyo, Japan), M. Suzuki (Tokyo, Japan), K. Morimoto (Tokyo, Japan), N. Hasegawa (Tokyo, Japan), S. Mitarai (Tokyo, Japan), M. Ato (Tokyo, Japan), Y. Hoshino (Tokyo, Japan)
| |
Phosphorothiorate oligodeoxynucleotides induce antimicrobial epithelial mitochondrial reactive oxygen species that protect against pneumonia Y. Wang (Houston, United States of America), V. Kulkarni (Houston, United States of America), J. Pantaleon Garcia (Houston, United States of America), M. Longmire (Houston, United States of America), S. Wali (Houston, United States of America), S. Evans (Houston, United States of America)
| |
Role of a-1 antitrypsin in lung protective immunity against Streptococcus pneumoniae in mice L. Ostermann (Hannover, Germany), R. Maus (Hannover, Germany), J. Stolper (Hannover, Germany), L. Schütte (Hannover, Germany), K. Katsarou (Hannover, Germany), C. Mueller (Worcester, United States of America), S. Janciauskiene (Hannover, Germany), T. Welte (Hannover, Germany), U. Maus (Hannover, Germany)
| |
Klebsiella pneumonae triggers rapid release IL(IL)-26 in human neutrophils K. Che (Stockholm, Sweden), A. Linden (Stockholm, Sweden)
| |
LSC - 2020 - IRF5 regulates airway macrophage metabolic responses to viral challenge G. Albers (London, United Kingdom)
| |
High Intensity Interval Training control inflammation in mice exposed to Streptococus pneumoniae. T. B.P Castro (Guarulhos, Brazil), R. M. Laia (São Paulo, Brazil), L. D. Mendonça (São Paulo, Brazil), P. Da Rocha Trindade (São Paulo, Brazil), J. C. Souza (São Paulo, Brazil), B. M. Saraiva-Romanholo (São Paulo, Brazil), M. S. Oliveira (São Paulo, Brazil), E. N. Miyagi (São Paulo, Brazil), C. M. Prado (São Paulo, Brazil), I. F.C.L Tiberio (São Paulo, Brazil), C. Rosa Olivo (São Paulo, Brazil)
| |
The effects of inhaled corticosteroids and a beta-2 agonist on C. pneumoniae-infected airway epithelial cells D. Paróczai (Deszk, Hungary), D. Kókai (Szeged, Hungary), K. Burián (Szeged, Hungary)
| |
Antimicrobial effect of hypertonic saline on sputum and biofilm in endotracheal tube S. Wang (Chiayi, Taiwan), H. Lin (Taoyuan, Taiwan), C. Chen (Hsinchu, Taiwan)
| |
Protective efficacy of virus like particles (VLPs) containing the influenza HA and/or NA in a murine model of postinfluenza bacterial pneumonia I. LENEVA (Moscow, Russian Federation), I. Falynskova (Moscow, Russian Federation), A. Egorov (Moscow, Russian Federation), A. Poddubikov (Moscow, Russian Federation), R. Grabherr (Vienna, Austria), M. Klausberger (Vienna, Austria)
| |
Monitoring opportunistic microflora in patients with HIV infection and highlighting the significance of Streptococcus gr. viridans in the development of lower respiratory tract infections A. Mordyk (Omsk, Russian Federation), L. Puzyreva (OmskOmsk, Russian Federation)
| |